University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Michael Aminoff, F.R.C.P., M.D.

Director of the Parkinson's Disease and Movement Disorders Clinic

Dr. Michael J. Aminoff is an internationally recognized neurologist and expert in diagnosing and treating Parkinson's disease. His work focuses on treating Parkinson's disease, particularly issues involving movement and cognition, such as memory disturbances, perception and judgment.

Aminoff was born and educated in England, graduating from University College London in 1962 and from University College Hospital Medical School in 1965. He subsequently trained in neurology and neurophysiology at The National Hospital (Queen Square) in London, and in 1974 moved to UCSF where he has been a professor of neurology since 1982. He was director of the Clinical Neurophysiology Laboratories at UCSF until 2004, when he became executive vice chair of the department. He also directs the Parkinson's Disease Clinic and Research Center, a National Parkinson Foundation Center of Excellence.

Aminoff is the author of over 225 published medical or scientific articles, as well as the author or editor of some 29 books. His published scientific contributions led to the award of a Doctorate in Science, an advanced doctorate in the Faculty of Science, by the University of London in 2000. He is one of two editors-in-chief of the four-volume Encyclopedia of the Neurological Sciences (2nd edition, Academic Press, 2014), and one of the series editors of the multi-volume Handbook of Clinical Neurology (Elsevier). He was editor-in-chief of the journal Muscle & Nerve from 1998 to 2007 and serves on numerous other editorial boards. He was a director of the American Board of Psychiatry and Neurology for eight years, and chair of the board in 2011.

Aminoff received the Lifetime Achievement Award from the American Association of Neuromuscular & Electrodiagnostic Medicine in 2006, and the A.B. Baker Award of the American Academy of Neurology, for lifetime achievements and contributions to medical education, in 2007.

He is married and has three children, one a pediatric rheumatologist, another a federal defense attorney and the third an assistant district attorney.

Clinics

Epilepsy Center
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2437
Fax: (415) 353-2837

Hours: Monday to Friday
8 a.m. – 5 p.m.

Parkinson's Disease and Movement Disorders Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2273
Fax: (415) 353-2898

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Michael Aminoff

Education

University of London 1965

Residencies

University College Hospital Medical School, United Kingdom, Neurology 1972

Selected Research and Publications

  1. Aminoff MJ, Boller F, Swaab DF. Foreword. Handb Clin Neurol. 2014; 121:vii.
  2. Aminoff MJ, Boller F, Swaab DF. Foreword. Handb Clin Neurol. 2014; 123:vii.
  3. Hess CP, Christine CW, Apple AC, Dillon WP, Aminoff MJ. Changes in the thalamus in atypical parkinsonism detected using shape analysis and diffusion tensor imaging. AJNR Am J Neuroradiol. 2014 May; 35(5):897-903.
  4. Dhand A, Aminoff MJ. The neurology of itch. Brain. 2014 Feb; 137(Pt 2):313-22.
  5. Asbury AK, Aminoff MJ. Prelude to the peripheral neuropathies. Handb Clin Neurol. 2013; 115:3-4.
  6. Aminoff MJ, Boller F, Swaab DF. Foreword. Handb Clin Neurol. 2013; 116:vii.
  7. Aminoff MJ, Boller F, Swaab DF. Foreword. Handb Clin Neurol. 2013; 118:vii.
  8. Aminoff MJ, Boller F, Swaab DF. Foreword. Handb Clin Neurol. 2013; 111:vii.
  9. Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Brühmann J, Brandt R, Christine CW, Aminoff MJ, Hellerstein MK. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest. 2012 Sep 4; 122(9):3159-69.
  10. Voss TS, Elm JJ, Wielinski CL, Aminoff MJ, Bandyopadhyay D, Chou KL, Sudarsky LR, Tilley BC. Fall frequency and risk assessment in early Parkinson's disease. Parkinsonism Relat Disord. 2012 Aug; 18(7):837-41.
  11. Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum Gene Ther. 2012 Apr; 23(4):377-81.
  12. Aminoff MJ, Boller F, Swaab DF. Parkinson's disease. Handb Clin Neurol. 2012; 103:ix.
  13. Gottwald MD, Aminoff MJ. Therapies for dopaminergic-induced dyskinesias in Parkinson disease. Ann Neurol. 2011 Jun; 69(6):919-27.
  14. Chou KL, Zamudio J, Schmidt P, Price CC, Parashos SA, Bloem BR, Lyons KE, Christine CW, Pahwa R, Bodis-Wollner I, Oertel WH, Suchowersky O, Aminoff MJ, Malaty IA, Friedman JH, Okun MS. Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. Parkinsonism Relat Disord. 2011 Jul; 17(6):440-5.
  15. Aminoff MJ, Boller F, Swaab DF. Hyperkinetic movement disorders. Foreword. Handb Clin Neurol. 2011; 100:vii.
  16. Aminoff MJ, Boller F, Swaab DF. We spend about one-third of our life either sleeping or attempting to do so. Handb Clin Neurol. 2011; 98:vii.
  17. Aminoff MJ, Boller F, Swaab DF. Muscular dystrophies. Foreword. Handb Clin Neurol. 2011; 101:vii.
  18. Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, Bloem BR, Parashos SA, Price CC, Malaty IA, Iansek R, Bodis-Wollner I, Suchowersky O, Oertel WH, Zamudio J, Oberdorf J, Schmidt P, Okun MS. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord. 2011 Mar; 17(3):139-45.
  19. Forsayeth J, Bankiewicz KS, Aminoff MJ. Gene therapy for Parkinson's disease: where are we now and where are we going? Expert Rev Neurother. 2010 Dec; 10(12):1839-45.
  20. Valles F, Fiandaca MS, Eberling JL, Starr PA, Larson PS, Christine CW, Forsayeth J, Richardson RM, Su X, Aminoff MJ, Bankiewicz KS. Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery. 2010 Nov; 67(5):1377-85.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.